HLA-DRB1 and myeloid sarcoma: Positions 11 and 71 of HLA-DRB1 have also been postulated to influence risk of IBD (17, 31), type 1 diabetes (32, 33), MS (34), sarcoidosis (35), and visceral leishmaniasis (36).